Abstract: In some embodiments, systems, apparatuses, and methods are provided herein useful to medical devices. In some embodiments, a medical device comprises a main body portion, the main body portion comprising a medication dispenser, a connection portion, wherein the connection portion is secured to a top of the main body portion, the connection portion comprising a needle, wherein the needle is located within a housing, and wherein the needle is communicatively coupled to the medication dispenser, the housing, wherein the housing includes a needle guard, wherein an upper surface of the needle guard extends beyond the needle, and a cover, wherein the cover is configured to seat on the connection portion, the cover comprising an outer cover, and an inner cover, wherein the inner cover is configured to seat on the needle, and wherein the inner cover and the outer cover form a single structure.

Abstract: An apparatus includes a chamber container and a tray. The chamber container has a first portion and a second portion removably coupled to the first portion. The first and second portions collectively define an inner volume. The tray is configured to be removably disposed within the inner volume of the chamber container. The tray includes a first portion and a second portion coupled to the first portion via a hinge. The first portion includes a first retention surface. The second portion includes a second retention surface. The tray is configured to receive a biodiffusion chamber between the first portion and the second portion such that the first retention surface and the second retention surface engage a portion of the biodiffusion chamber to (1) place the biodiffusion chamber in a predetermined orientation and (2) maintain the biodiffusion chamber in a substantially fixed position relative to the tray.

Abstract: The present disclosure provides a ready-to-use liquid formulation comprising bupivacaine hydrochloride, dexamethasone sodium phosphate and epinephrine (collectively referred to as Bupivisone Plus), and methods for preparing, packaging, storing and using the same.

Abstract: A biodiffusion chamber for performing autologous cell vaccination is provided. The biodiffusion chamber is adapted for insertion into and removal from a subject. In some embodiments, the biodiffusion chamber comprises (i) a chamber body defining a hollow cavity and including a first surface and a second surface, (ii) a first semi-permeable membrane coupled to the first surface, (iii) a second semi-permeable membrane coupled to the second surface, and (iv) an element and/or feature adapted for removing the biodiffusion chamber from the subject. The first semi-permeable membrane and the second semi-permeable membrane are permeable to fluids and soluble factors but are not permeable to cells.

Abstract: Disclosed herein is a manufacturing process for the preparation of tigecycline suitable for intravenous infusion.

Abstract: Disclosed herein is a manufacturing process for the preparation of tigecycline suitable for intravenous infusion.

Abstract: A hypodermic syringe tray adapted to hold at least one hypodermic syringe, comprising a barrel, plunger, cannula and cannula cover, in such manner as to secure said cannula cover and said plunger during thermal sterilization of the syringe and its contents.